Product Name | Anti-Human CD49d Monoclonal Antibody(Natalizumab) |
---|---|
CAS | 189261-10-7 |
Storage condition | Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
1 mg | 3-5days | ¥2000.00 | Visible after login | |
5 mg | 3-5days | ¥7500.00 | Visible after login | |
10 mg | 3-5days | ¥12000.00 | Visible after login | |
50 mg | 3-5days | ¥28000.00 | Visible after login | |
100 mg | 3-5days | ¥45600.00 | Visible after login |
Product Name | Anti-Human CD49d Monoclonal Antibody(Natalizumab) |
---|---|
CAS | 189261-10-7 |
Storage condition | Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses.